S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

HRTX Heron Therapeautics Inc

2.33

0.01 (0.43%)

Pre Market

Last Updated: 07:38:29

Delayed by 15 minutes

Heron Therapeutics climbs on management comments on upcoming milestone

To read the full story on Seeking Alpha, click here.

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Heron Therapeautics Charts.

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Heron Therapeautics Charts.

Heron Therapeautics Inc News

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Wednesday 24 April 2024 (1 week ago) • PR Newswire (US)

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Thursday 11 April 2024 (3 weeks ago) • PR Newswire (US)

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Thursday 28 March 2024 (1 month ago) • PR Newswire (US)

Biotech Finds Mid-Week Success Following Q4 Earnings Release
Wednesday 13 March 2024 (2 months ago) • AllPennyStocks.com

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
Tuesday 12 March 2024 (2 months ago) • PR Newswire (US)

Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading
Tuesday 12 March 2024 (2 months ago) • IH Market News

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Premarket Heats Up For Biotech Before Opening Bell
Wednesday 24 January 2024 (3 months ago) • AllPennyStocks.com

Form 8-K - Current report
Wednesday 24 January 2024 (3 months ago) • Edgar (US Regulatory)

Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
Tuesday 23 January 2024 (3 months ago) • PR Newswire (US)

More Heron Therapeautics Inc News Articles

Yuenglings Ice Cream (PK)

Virexit Technologies (PK)

Elite Pharmaceuticals (QB)

BlueFire Equipment (PK)

FuelCell Energy

Tonner One World (PK)

Branded Legacy (PK)

Canopus Biopharma (PK)

Global Developments (PK)

Globestar Therapeutics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions